| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 726365 | Null | 0.0238174255956147 | -0.018288511 |
| NSC 748382 | Null | 0.0238174255956147 | 0.046543498 |
| NSC 753188 | 4-chloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide | 0.0238174255956147 | 0.2569318 |
| NSC 107043 | Null | 0.024108502230778 | 0.24585118 |
| NSC 130279 | 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,4-dihydro-3-.beta.-D-ribofuranosyl- (9CI) | 0.024108502230778 | -0.10135894 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.024108502230778 | 0.23737537 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.024108502230778 | -0.13944406 |
| NSC 144163 | Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- | 0.024108502230778 | 0.047544228 |
| NSC 626676 | Null | 0.024108502230778 | 0.22472835 |
| NSC 628949 | Null | 0.024108502230778 | 0.22968006 |